Clinical Trial Update: Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tolerability of device-based therapies for cutaneous neurofibromas in Neurofibromatosis type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cutaneous Neurofibroma | Phase 1 | Status: COMPLETED